USPH Net Income Applicable To Common Shares from 2010 to 2026
| USPH Stock | USD 84.48 1.10 1.29% |
Net Income Applicable To Common Shares | First Reported 2000-03-31 | Previous Quarter 10.9 M | Current Value 7.6 M | Quarterly Volatility 3.2 M |
Check US Physicalrapy financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among US Physicalrapy's main balance sheet or income statement drivers, such as Interest Expense of 9.7 M, Total Revenue of 810.6 M or Gross Profit of 149.6 M, as well as many indicators such as Price To Sales Ratio of 2.96, Dividend Yield of 0.0195 or PTB Ratio of 4.65. USPH financial statements analysis is a perfect complement when working with US Physicalrapy Valuation or Volatility modules.
USPH | Net Income Applicable To Common Shares | Build AI portfolio with USPH Stock |
The Net Income Applicable To Common Shares trend for US Physicalrapy offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether US Physicalrapy is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest US Physicalrapy's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of US Physicalrapy over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. US Physicalrapy's Net Income Applicable To Common Shares historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in US Physicalrapy's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
USPH Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | 25,499,528 | |
| Geometric Mean | 22,861,774 | |
| Coefficient Of Variation | 38.61 | |
| Mean Deviation | 8,044,479 | |
| Median | 22,279,000 | |
| Standard Deviation | 9,846,260 | |
| Sample Variance | 96.9T | |
| Range | 37.1M | |
| R-Value | 0.63 | |
| Mean Square Error | 61.8T | |
| R-Squared | 0.40 | |
| Significance | 0.01 | |
| Slope | 1,236,276 | |
| Total Sum of Squares | 1551.2T |
USPH Net Income Applicable To Common Shares History
About US Physicalrapy Financial Statements
Investors use fundamental indicators, such as US Physicalrapy's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although US Physicalrapy's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Net Income Applicable To Common Shares | 33.7 M | 19.8 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of US Physicalrapy Correlation against competitors. For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is there potential for Health Care Providers & Services market expansion? Will USPH introduce new products? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.236 | Dividend Share 1.79 | Earnings Share 2.34 | Revenue Per Share | Quarterly Revenue Growth 0.173 |
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, US Physicalrapy's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.